Journal profile · Medicine-Urology
Bladder Cancer
ISSN 2352-3727 · eISSN 2352-3735 · SAGE Publications (formerly IOS Press) · NETHERLANDS
Bladder Cancer: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.73; fully open access; APC about USD 2,800; median 112 days to acceptance (51 articles, last 24 months); 28 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Bladder Cancer is published by SAGE Publications (formerly IOS Press) and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies and Urological Disorders and Treatments, together about 65.8% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Bladder Cancer is an international multidisciplinary journal aiming to facilitate progress in understanding the epidemiology, etiology, molecular genetics, pathogenesis, pathobiology and pharmacology of tumors of the bladder and upper urinary …
From the journal's Aims & Scope
Research area (LetPub): Medicine-Urology
Editor-in-chief Seth P. LernerPublisher website
Editorial board by country: none in mainland China; most named United States 87, Germany 11, United Kingdom 5, Spain 5, Canada 5 (141 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bladder and Urothelial Cancer TreatmentsMedicine38.9%
- Urinary and Genital Oncology StudiesMedicine21.3%
- Urological Disorders and TreatmentsMedicine5.6%
- Urinary Bladder and Prostate ResearchMedicine3.4%
- Urinary Tract Infections ManagementMedicine3.1%
- Cancer Immunotherapy and BiomarkersMedicine3%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology2.8%
- Esophageal Cancer Research and TreatmentMedicine2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.73LetPub ·
- Impact factor (publisher)
- 2.2Publisher website ·
- 5-year impact factor (publisher)
- 1.7Publisher website ·
- CiteScore 2026-06
- 2.1LetPub ·
- SJR 2026-06
- 0.6LetPub ·
- SNIP 2026-06
- 0.56LetPub ·
- h-index
- 37OpenAlex ·
- i10-index
- 154OpenAlex ·
- 2-year mean citedness
- 2.29OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 88.46%LetPub ·
Volume
- Articles per year
- 23LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 684 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 24 | 4 |
| 2025 | 28 | 28 | 72 |
| 2024 | 27 | 27 | 105 |
| 2023 | 40 | 40 | 111 |
| 2022 | 35 | 35 | 152 |
| 2021 | 99 | 59 | 214 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
112 daysMedian, submission to acceptance · P25–P75 73 days – 165 days
- Acceptance to online
- median 33 days (51 articles)
- Submission to online
- median 156 days
- Sample
- 51 articles with submission and acceptance dates (65 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 20 weeksLetPub ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,800 | Yes | CC BY, CC BY-NC | |
| LetPub | USD 750 | Yes | — | |
| Publisher website | USD 3,200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Manuscript length
- ≤ 4,000 words
- Reference style
- Vancouver
- Suggested reviewers
- Required
- Cover letter
- Required
Article types accepted18, with length limits
- book reviewResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …Length not stated
- book reviewsBook Reviews Book reviews should be 750 words or less and without sections.Length not stated
- brief reportResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …Length not stated
- commentariesCommentaries Commentaries can be around 1000 words with an abstract and no other subdivisions.Length not stated
- commentaryResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …main text ≤ 1,000 words
- editorialResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …Length not stated
- full articleResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …Length not stated
- hypothesesHypotheses A hypothesis article should be a balanced and insightful consideration of a topic with novel hypotheses well presented and supported.Length not stated
- hypothesisResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …Length not stated
- letters to the editorResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …main text ≤ 1,000 words
- research articleResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …main text ≤ 4,000 words
- research reportResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …Length not stated
- research reportsArticle types Research ReportsLength not stated
- reviewResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …Length not stated
- reviewsReviews Reviews should be authoritative and topical and provide comprehensive and balanced coverage of a timely and/or controversial issue.Length not stated
- short communicationResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …main text ≤ 1,500 words
- short communications/brief reportsShort Communications/Brief Reports Short Communications and Brief Reports are articles of original scholarship of unusual interest of less than 1500 words (not …Length not stated
- systematic reviewResearch Reports Organization and style of presentation Manuscripts must be written in US English. Authors whose native language is not English are recommended …Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
Bladder Cancer is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by the funder, in…
Source ↗Publisher website ·- Peer review Peer review policy
Single anonymized peer review Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publications (formerly IOS Press)
- Country or region
- NETHERLANDS
- Language
- English
- ISSN
- 2352-3727
- Electronic ISSN
- 2352-3735
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Bladder Cancer
What CAS zone is Bladder Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Bladder Cancer is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology / Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Bladder Cancer?
The latest impact factor listed by LetPub is 1.73; CiteScore 2.1, h-index 37.
How long does peer review take at Bladder Cancer?
Based on the dates recorded on 51 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 112 days (interquartile range 73–165 days); authors report an average review time of about 20 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Bladder Cancer?
According to the journal's author guidelines: Manuscript length: ≤ 4,000 words; Reference style: Vancouver; Suggested reviewers: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Bladder Cancer based?
Of the 141 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (87), Germany (11) and United Kingdom (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Bladder Cancer?
According to LetPub and DOAJ records, Bladder Cancer is indexed in SCIE, Scopus and DOAJ.
Is Bladder Cancer open access, and what is the APC?
Bladder Cancer is a fully open-access journal. APC about USD 2,800.
Sources and updates
The facts on this page come from LetPub, DOAJ, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .